Replies to post #90158 on DD Support Board and Research Team

[elbiatcho1]

Ampligen in cigarettes.
Classic!

Carter also had plans to treat tobacco with Ampligen and create a "healthy" cigarette.

http://www.rttnews.com/2011750/can-hemispherx-s-ampligen-see-happy-ending-to-long-fatiguing-wait.aspx

About as entertaining as NASCAR Race Fumes in a can!

HEB sue Adam Feuerstein yet?

[Jamesripp]

No thanks. You sound committed to ignoring the most recent facts about the company so I'm done engaging with you.

[DragonBear]

Since the 1980's, how many drugs has HEB

or it's predecessor company gotten approved by the FDA and what is the aggregate amount of money that HEB and its predecessor company has received since the 1980s?

That's not playing fair shajandr! One is not suppose to bring up past failures. Only future dreams for the purpose of "DD". Although I guess my request for a link to any completed Phase III trials isn't very fair either.

Once upon a time I had a good run in Genetech. It's behavior was a little boost in the stock price for Phase I trials being completed successfully. Then another small pop upon successful Phase II. About midway through Phase III the company might update, and a large pop. Of course a successful Phase III completed, and it would really run. This with a biotech which had a very good track record in getting FDA approvals. Other biotechs behave in a like manner. The big kids wait for progressive results.

Fast forward and we have the penny wonder HEB. No track record for getting FDA approvals. The EU grants orphan status for its use against Ebola, and penny investors are suppose to celebrate, throwing puppies and kittens into the air. The PPS predicted to go to da moon, as retail gulps the stock until they Burp. The absence of clinical trials are of no importance in the penny world. Pretend they are not needed or required. Such things get in the way of penny dreams.

[shajandr]

"by trying to present the most current facts about this company and its products."

What qualifies YOU to offer such "facts" and opinions?

Do you have a scientific degree that allows you a foundation to evaluate and understand such "facts"?

Do you have experience in the pharmaceutical/biopharmaceutical industry that allows you to understand in detail the regulatory process to license a biological (or chemical) as a licensed drug in the USA or EU?

Why would YOU feel competent to write an article on SeekingAlpha to provide advice and opinion to prospective investors (the target audience of SeekingAlpha) if you lacked such fundamental foundational background?

Was your intent to promote the stock? If not, why did you decide to write an article on a website that is directed at investors, rather than say a webiste directed at patients or scientists?

Quite curious, no?

[Zorax]

Reality and truth are not allowed as DD reporting requirements for awareness campaigns.
What were you thinking?